DK285077A - Fremgangsmade til fremstilling af isoquinolinderivater - Google Patents

Fremgangsmade til fremstilling af isoquinolinderivater

Info

Publication number
DK285077A
DK285077A DK285077A DK285077A DK285077A DK 285077 A DK285077 A DK 285077A DK 285077 A DK285077 A DK 285077A DK 285077 A DK285077 A DK 285077A DK 285077 A DK285077 A DK 285077A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
isoquinoline derivatives
isoquinoline
derivatives
Prior art date
Application number
DK285077A
Other languages
English (en)
Inventor
J M Bastian
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH863276A external-priority patent/CH622783A5/de
Priority claimed from CH863176A external-priority patent/CH622782A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK285077A publication Critical patent/DK285077A/da
Priority to DK93282A priority Critical patent/DK93282A/da
Priority to DK93382A priority patent/DK93382A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/08Aza-anthracenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK285077A 1976-07-06 1977-06-27 Fremgangsmade til fremstilling af isoquinolinderivater DK285077A (da)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DK93282A DK93282A (da) 1976-07-06 1982-03-03 Fremgangsmaade til fremstilling af benz(g)isoquinolinderivater
DK93382A DK93382A (da) 1976-07-06 1982-03-03 Fremgangsmaade til fremstilling af benz(g)isoquinolinderivater

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH863276A CH622783A5 (en) 1976-07-06 1976-07-06 Process for the preparation of novel hexahydrobenz[g]isoquinoline derivatives
CH863176A CH622782A5 (en) 1976-07-06 1976-07-06 Process for the preparation of novel hexahydrobenz[g]isoquinoline derivatives

Publications (1)

Publication Number Publication Date
DK285077A true DK285077A (da) 1978-01-07

Family

ID=25703556

Family Applications (1)

Application Number Title Priority Date Filing Date
DK285077A DK285077A (da) 1976-07-06 1977-06-27 Fremgangsmade til fremstilling af isoquinolinderivater

Country Status (19)

Country Link
US (1) US4150136A (da)
JP (1) JPS537681A (da)
AT (1) AT366369B (da)
CA (1) CA1094561A (da)
DE (1) DE2728831A1 (da)
DK (1) DK285077A (da)
ES (2) ES460371A1 (da)
FI (1) FI65242C (da)
FR (1) FR2357547A1 (da)
GB (1) GB1582783A (da)
IE (1) IE45241B1 (da)
IL (1) IL52449A (da)
MY (1) MY8400058A (da)
NL (1) NL7707307A (da)
NZ (1) NZ184547A (da)
PH (1) PH14074A (da)
PT (1) PT66758B (da)
SE (2) SE7707445L (da)
SU (1) SU692559A3 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678791A (en) * 1985-05-07 1987-07-07 Pennwalt Corporation 6-phenyl-1,2-3,4,4a,5-6,10b-octahydrobenz(h)isoquinolines useful for treating depression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325803A (en) * 1964-10-01 1967-06-13 Ibm Deflection control circuit

Also Published As

Publication number Publication date
SE7707445L (sv) 1978-01-07
PT66758B (fr) 1979-03-12
FR2357547A1 (fr) 1978-02-03
NL7707307A (nl) 1978-01-10
JPS537681A (en) 1978-01-24
US4150136A (en) 1979-04-17
DE2728831A1 (de) 1978-01-19
IE45241L (en) 1978-01-06
SE8207394L (sv) 1982-12-23
SU692559A3 (ru) 1979-10-15
MY8400058A (en) 1984-12-31
AT366369B (de) 1982-04-13
IL52449A0 (en) 1977-10-31
NZ184547A (en) 1980-08-26
IE45241B1 (en) 1982-07-14
ATA477577A (de) 1981-08-15
PT66758A (fr) 1977-08-01
FI771986A (da) 1978-01-07
GB1582783A (en) 1981-01-14
CA1094561A (en) 1981-01-27
IL52449A (en) 1981-09-13
ES476889A1 (es) 1979-07-16
FI65242C (fi) 1984-04-10
PH14074A (en) 1981-01-26
FR2357547B1 (da) 1980-02-15
FI65242B (fi) 1983-12-30
AU2677177A (en) 1979-01-11
ES460371A1 (es) 1979-05-01
SE8207394D0 (sv) 1982-12-23

Similar Documents

Publication Publication Date Title
DK357976A (da) Fremgangsmade til fremstilling af tetrahydroisoquinolinderivater
DK142372C (da) Fremgangsmaade til fremstilling af androstan-17-on-derivater
DK377A (da) Fremgangsmade til fremstilling af n-phosphonomethyl-glycin
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
DK37376A (da) Fremgangsmade til fremstilling af tetrahydroisoquinolinderivater
DK577977A (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalanin-methyler
DK271977A (da) Fremgangsmade til fremstilling af dispeptidderivater
DK339677A (da) Fremgangsmade til fremstilling af 2-benzylpyrrolidiner
DK46577A (da) Fremgangsmade til fremstilling af tetrahydroechinocandinderivater
DK118177A (da) Fremgangsmade til fremstilling af isobutyramidderivater
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
DK27178A (da) Fremgangsmaade til fremstilling af isoquinolinderivater
DK216977A (da) Fremgangsmade til fremstilling af imidazobenzoxaziner
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK19278A (da) Fremgangsmaade til fremstilling af isoquinolinderivater
DK264377A (da) Fremgangsmade til fremstilling af 1alfa-hydroxycholesterol-derivater
DK116976A (da) Fremgangsmade til fremstilling af isoquinolinderivater
DK430579A (da) Fremgangsmaade til fremstilling af isoquinolinderivater
DK499878A (da) Fremgangsmaade til fremstilling af isoquinolinderivater
DK196577A (da) Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester
DK538977A (da) Fremgangsmaade til fremstilling af 17alfa-hydroxy-21-acetoxy-progesteron
DK88279A (da) Fremgangsmaade til fremstilling af isoquinolinderivater
DK553077A (da) Fremgangsmaade til fremstilling af n-propylnorapomorphindiestere
DK106677A (da) Fremgangsmade til fremstilling af 3-nethylencephalosporiner
DK338677A (da) Frefmgangsmade til fremstilling af 3-alkoxycyproheptadiner

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment